Sulfonylurea
Pregnancy: C — not recommended; insulin preferred
Gliclazide
Brand names: Diamicron, Diamicron MR
Adult dose
Dose: 40–160mg twice daily (IR) or 30–120mg once daily (MR)
Route: Oral
Frequency: Twice daily (IR) or once daily (MR) with breakfast
MR: start 30mg OD. Standard: start 40mg OD. Titrate every 4 weeks. Max 320mg/day (IR) or 120mg/day (MR).
Clinical pearls
- Preferred sulfonylurea over glibenclamide — lower hypoglycaemia risk (particularly in elderly)
- Take with or just before meals — advise patients never to skip meals
- Modified-release once daily improves adherence
- Safer in mild-moderate renal impairment compared to other sulfonylureas
- Second-line after metformin if HbA1c not controlled
Contraindications
- Type 1 diabetes
- DKA
- Severe renal impairment (eGFR <30)
- Sulfonamide allergy
Side effects
- Hypoglycaemia (risk lower than glibenclamide)
- Weight gain
- GI upset
- Hyponatraemia
Interactions
- NSAIDs, fluconazole, clarithromycin — enhance hypoglycaemic effect
- Rifampicin, corticosteroids — reduce efficacy
Monitoring
- HbA1c (3–6 monthly)
- eGFR annually
- Capillary glucose (if symptoms of hypoglycaemia)
Reference: NICE NG28; Scottish Medicines Consortium. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016